EN 中文 DE FR عربى

Synlait Sells Assets to Abbott for $307 Million to Reduce Debt

New Zealand 25.11.2025
Sourse: dairynews.today
663 EN 中文 DE FR عربى
Synlait Milk, a significant player in the nutrition and infant formula industry, has finalized the sale of its North Island assets, including the Pōkeno manufacturing facility, to Abbott Laboratories for about NZ$307 million (US$178 million).
Synlait Sells Assets to Abbott for $307 Million to Reduce Debt

This transaction is supported by Bright Dairy Holding, which holds a 65.25% stake in Synlait, ensuring shareholder approval.

The asset sale is primarily aimed at reducing Synlait's debt, which stood at around NZ$250.7 million. The proceeds are expected to eliminate the company's term debt by the targeted completion date of April 1, 2026. Despite reporting a full-year loss of $39.8 million due to past manufacturing issues, this move strategically positions Synlait for future growth.

Beyond financial stabilization, Synlait is shifting its focus to its South Island facilities, emphasizing high-value nutritional products over large-scale commodity processing. This strategic pivot is part of an 'orderly transition' as Synlait's key customer, The a2 Milk Company, diversifies its supply chain.


Key News of the Week
December 2025
  • Mo
  • Tu
  • We
  • Th
  • Fr
  • Sa
  • Su
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
Calendar